Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 116 articles:
HTML format

Single Articles

    January 2022
  1. RADFORD-SMITH DE, Patel PJ, Irvine KM, Russell A, et al
    Depressive symptoms in non-alcoholic fatty liver disease are identified by perturbed lipid and lipoprotein metabolism.
    PLoS One. 2022;17:e0261555.
    PubMed     Abstract available

  2. S HASHEMI N, Skogen JC, Sevic A, Thorrisen MM, et al
    A systematic review and meta-analysis uncovering the relationship between alcohol consumption and sickness absence. When type of design, data, and sickness absence make a difference.
    PLoS One. 2022;17:e0262458.
    PubMed     Abstract available

  3. POWELL LM, Leider J
    Impact of the Seattle Sweetened Beverage Tax on substitution to alcoholic beverages.
    PLoS One. 2022;17:e0262578.
    PubMed     Abstract available

  4. JOLEX A, Kaluwa B
    Crowding Out Effects of Alcohol Consumption Expenditure on Household Resource Allocation in Malawi.
    PLoS One. 2022;17:e0263330.
    PubMed     Abstract available

  5. TOVMASYAN A, Monk RL, Heim D
    Towards an affect intensity regulation hypothesis: Systematic review and meta-analyses of the relationship between affective states and alcohol consumption.
    PLoS One. 2022;17:e0262670.
    PubMed     Abstract available

  6. ASADULLAH M, Shivashankar R, Shalimar, Kandasamy D, et al
    Rural-Urban differentials in prevalence, spectrum and determinants of Non-alcoholic Fatty Liver Disease in North Indian population.
    PLoS One. 2022;17:e0263768.
    PubMed     Abstract available

  7. THOMAS KL, Root CL, Peterson JM
    Transgenic overexpression of CTRP3 does not prevent alcohol induced hepatic steatosis in female mice.
    PLoS One. 2022;17:e0258557.
    PubMed     Abstract available

  8. FERNANDEZ T, Vinuela M, Vidal C, Barrera F, et al
    Lifestyle changes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0263931.
    PubMed     Abstract available

  9. MORISHITA A, Tadokoro T, Fujihara S, Iwama H, et al
    Ipragliflozin attenuates non-alcoholic steatohepatitis development in an animal model.
    PLoS One. 2022;17:e0261310.
    PubMed     Abstract available

  10. CHOSY EJ, Edland S, Launer L, White LR, et al
    Midlife alcohol consumption and later life cognitive impairment: Light drinking is not protective and APOE genotype does not change this relationship.
    PLoS One. 2022;17:e0264575.
    PubMed     Abstract available

  11. SANTOS MGR, Sanchez ZM, Hughes K, Gee I, et al
    Pre-drinking, alcohol consumption and related harms amongst Brazilian and British university students.
    PLoS One. 2022;17:e0264842.
    PubMed     Abstract available

  12. HAMADA S, Takata T, Yamada K, Yamamoto M, et al
    Steatosis is involved in the progression of kidney disease in a high-fat-diet-induced non-alcoholic steatohepatitis mouse model.
    PLoS One. 2022;17:e0265461.
    PubMed     Abstract available

  13. KIMER N, Meldgaard M, Hamberg O, Kronborg TM, et al
    The impact of rifaximin on inflammation and metabolism in alcoholic hepatitis: A randomized clinical trial.
    PLoS One. 2022;17:e0264278.
    PubMed     Abstract available

  14. DONOGHUE K, Hermann L, Brobbin E, Drummond C, et al
    The rates and measurement of adherence to acamprosate in randomised controlled clinical trials: A systematic review.
    PLoS One. 2022;17:e0263350.
    PubMed     Abstract available

  15. ANENI EC, Saeed GJ, Bittencourt MS, Cainzos-Achirica M, et al
    Cardiometabolic disorders, inflammation and the incidence of non-alcoholic fatty liver disease: A longitudinal study comparing lean and non-lean individuals.
    PLoS One. 2022;17:e0266505.
    PubMed     Abstract available

  16. CAROL M, Perez-Guasch M, Sola E, Cervera M, et al
    Stigmatization is common in patients with non-alcoholic fatty liver disease and correlates with quality of life.
    PLoS One. 2022;17:e0265153.
    PubMed     Abstract available

  17. SALMAN M, Kamel MA, El-Nabi SEH, Ismail AHA, et al
    The regulation of HBP1, SIRT1, and SREBP-1c genes and the related microRNAs in non-alcoholic fatty liver rats: The association with the folic acid anti-steatosis.
    PLoS One. 2022;17:e0265455.
    PubMed     Abstract available

  18. SARMADI N, Poustchi H, Ali Yari F, Radmard AR, et al
    Anti-inflammatory function of apolipoprotein B-depleted plasma is impaired in non-alcoholic fatty liver disease.
    PLoS One. 2022;17:e0266227.
    PubMed     Abstract available

  19. KUMAR RG, Esterov D, Adams RS, Corrigan JD, et al
    Changes in alcohol use and mood during the COVID-19 pandemic among individuals with traumatic brain injury: A difference-in-difference study.
    PLoS One. 2022;17:e0266422.
    PubMed     Abstract available

  20. KOVACS I, Gal BI, Horvath Z, Demeter I, et al
    Externalizing personality characteristics define clinically relevant subgroups of alcohol use disorder.
    PLoS One. 2022;17:e0265577.
    PubMed     Abstract available

  21. SUBHANI M, Talat U, Knight H, Morling JR, et al
    Characteristics of alcohol recovery narratives: Systematic review and narrative synthesis.
    PLoS One. 2022;17:e0268034.
    PubMed     Abstract available

  22. ACHARYA B, Dhakal C
    Risky health behaviors during the COVID-19 pandemic: Evidence from the expenditures on alcohol, non-alcoholic beverages, and tobacco products.
    PLoS One. 2022;17:e0268068.
    PubMed     Abstract available

  23. TAKATS A, Berke G, Gede N, Nemeth BC, et al
    Risk of chronic pancreatitis in carriers of loss-of-function CTRC variants: A meta-analysis.
    PLoS One. 2022;17:e0268859.
    PubMed     Abstract available

  24. RIVERA AC, LeardMann CA, Rull RP, Cooper A, et al
    Combat exposure and behavioral health in U.S. Army Special Forces.
    PLoS One. 2022;17:e0270515.
    PubMed     Abstract available

  25. PARCESEPE AM, Filiatreau LM, Ebasone PV, Dzudie A, et al
    Psychiatric comorbidity and psychosocial stressors among people initiating HIV care in Cameroon.
    PLoS One. 2022;17:e0270042.
    PubMed     Abstract available

  26. KIM N, Roh JH, Lee H, Kim D, et al
    The impact of non-alcoholic fatty liver disease on sleep apnea in healthy adults: A nationwide study of Korea.
    PLoS One. 2022;17:e0271021.
    PubMed     Abstract available

  27. ZETTERSTROM A, Dahlberg G, Lundqvist S, Hamalainen MD, et al
    Processing incomplete questionnaire data into continuous digital biomarkers for addiction monitoring.
    PLoS One. 2022;17:e0271465.
    PubMed     Abstract available

  28. JAYATHILAKA R, Athukorala O, Ishara S, Silva D, et al
    Alcohol brings burdens: A global and continent wise study on alcohol consumption and global burden of diseases.
    PLoS One. 2022;17:e0270998.
    PubMed     Abstract available

  29. DIESE EL, Raines-Milenkov A, Felini M, Akpan I, et al
    Alcohol use among Congolese Babembe male refugees in Tarrant County: A qualitative study.
    PLoS One. 2022;17:e0272293.
    PubMed     Abstract available

  30. DE OLIVEIRA SANTOS EG, Vedana KGG, Barbosa IR
    Prevalence and factors associated with suicidal ideation among farmers.
    PLoS One. 2022;17:e0273625.
    PubMed     Abstract available

  31. HEREDIA JE, Sorenson C, Flanagan S, Nunez V, et al
    IL-23 signaling is not an important driver of liver inflammation and fibrosis in murine non-alcoholic steatohepatitis models.
    PLoS One. 2022;17:e0274582.
    PubMed     Abstract available

  32. OKOYO C, Njambi E, Were V, Araka S, et al
    Prevalence, types, patterns and risk factors associated with drugs and substances of use and abuse: A cross-sectional study of selected counties in Kenya.
    PLoS One. 2022;17:e0273470.
    PubMed     Abstract available

    January 2021
  33. PEDRONI C, Dujeu M, Lebacq T, Desnouck V, et al
    Alcohol consumption in early adolescence: Associations with sociodemographic and psychosocial factors according to gender.
    PLoS One. 2021;16:e0245597.
    PubMed     Abstract available

  34. ESTRADA-MARTINEZ S, Perez-Alamos AR, Ibarra-Segovia M, Beristain-Garcia I, et al
    Seroepidemiology of Toxoplasma gondii infection in people with alcohol consumption in Durango, Mexico.
    PLoS One. 2021;16:e0245701.
    PubMed     Abstract available

  35. LIN X, You F, Liu H, Fang Y, et al
    Site-specific risk of colorectal neoplasms in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0245921.
    PubMed     Abstract available

  36. Correction: Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis.
    PLoS One. 2021;16:e0247690.
    PubMed     Abstract available

  37. HENNEIN R, Mew EJ, Lowe SR
    Socio-ecological predictors of mental health outcomes among healthcare workers during the COVID-19 pandemic in the United States.
    PLoS One. 2021;16:e0246602.
    PubMed     Abstract available

  38. DARLING KEA, Locatelli I, Benghalem N, Nadin I, et al
    Alcohol consumption and neurocognitive deficits in people with well-treated HIV in Switzerland.
    PLoS One. 2021;16:e0246579.
    PubMed     Abstract available

  39. SENGUPTA M, Abuirqeba S, Kameric A, Cecile-Valfort A, et al
    A two-hit model of alcoholic liver disease that exhibits rapid, severe fibrosis.
    PLoS One. 2021;16:e0249316.
    PubMed     Abstract available

  40. ARIYA M, Koohpayeh F, Ghaemi A, Osati S, et al
    Assessment of the association between body composition and risk of non-alcoholic fatty liver.
    PLoS One. 2021;16:e0249223.
    PubMed     Abstract available

  41. KURODA H, Fujiwara Y, Abe T, Nagasawa T, et al
    Two-dimensional shear wave elastography and ultrasound-guided attenuation parameter for progressive non-alcoholic steatohepatitis.
    PLoS One. 2021;16:e0249493.
    PubMed     Abstract available

  42. D'AMBROSIO R, Campi I, Maggioni M, Perbellini R, et al
    The relationship between liver histology and thyroid function tests in patients with non-alcoholic fatty liver disease (NAFLD).
    PLoS One. 2021;16:e0249614.
    PubMed     Abstract available

  43. BAE CR, Zhang H, Kwon YG
    Correction: The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice.
    PLoS One. 2021;16:e0249747.
    PubMed     Abstract available

  44. KOUTOUKIDIS DA, Morris E, Henry JA, Shammoon Y, et al
    What proportion of people have a follow-up biopsy in randomized trials of treatments for non-alcoholic steatohepatitis?: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0250385.
    PubMed     Abstract available

  45. TAHA MM, Aneis YM, Mohamady HM, S A A, et al
    Effect of focused ultrasound cavitation augmented with aerobic exercise on abdominal and intrahepatic fat in patients with non-alcoholic fatty liver disease: A randomized controlled trial.
    PLoS One. 2021;16:e0250337.
    PubMed     Abstract available

  46. CONGLY SE, Shaheen AA, Swain MG
    Modelling the cost effectiveness of non-alcoholic fatty liver disease risk stratification strategies in the community setting.
    PLoS One. 2021;16:e0251741.
    PubMed     Abstract available

  47. YEN HH, Su PY, Huang SP, Wu L, et al
    Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study.
    PLoS One. 2021;16:e0252286.
    PubMed     Abstract available

  48. KIM JY, Park YM, Lee GN, Song HC, et al
    Association between toothbrushing and non-alcoholic fatty liver disease.
    PLoS One. 2021;16:e0243686.
    PubMed     Abstract available

  49. DAYTON KA, Bril F, Barb D, Lai J, et al
    Severity of non-alcoholic steatohepatitis is not linked to testosterone concentration in patients with type 2 diabetes.
    PLoS One. 2021;16:e0251449.
    PubMed     Abstract available

  50. RENNERT-MAY E, Leal J, Thanh NX, Lang E, et al
    The impact of COVID-19 on hospital admissions and emergency department visits: A population-based study.
    PLoS One. 2021;16:e0252441.
    PubMed     Abstract available

  51. SUKAHRI S, Mohamed Shah FZ, Ismail AI, Koshy M, et al
    Significantly higher atherosclerosis risks in patients with obstructive sleep apnea and non-alcoholic fatty liver disease.
    PLoS One. 2021;16:e0253298.
    PubMed     Abstract available

  52. MORAN MW, Ramirez EP, Zook JD, Saarinen AM, et al
    Biophysical characterization and a roadmap towards the NMR solution structure of G0S2, a key enzyme in non-alcoholic fatty liver disease.
    PLoS One. 2021;16:e0249164.
    PubMed     Abstract available

  53. PRO G, Gilbert PA, Baldwin JA, Brown CC, et al
    Multilevel modeling of county-level excessive alcohol use, rurality, and COVID-19 case fatality rates in the US.
    PLoS One. 2021;16:e0253466.
    PubMed     Abstract available

  54. YOKOYAMA A, Yokoyama T, Kimura M, Matsushita S, et al
    Combinations of alcohol-induced flushing with genetic polymorphisms of alcohol and aldehyde dehydrogenases and the risk of alcohol dependence in Japanese men and women.
    PLoS One. 2021;16:e0255276.
    PubMed     Abstract available

  55. LEE Y, Mun E, Park S, Lee W, et al
    Long working hours are associated with a higher risk of non-alcoholic fatty liver disease: A large population-based Korean cohort study.
    PLoS One. 2021;16:e0255118.
    PubMed     Abstract available

  56. ERIKSEN LL, Nielsen MA, Laursen TL, Deleuran B, et al
    Early loss of T lymphocyte 4-1BB receptor expression is associated with higher short-term mortality in alcoholic hepatitis.
    PLoS One. 2021;16:e0255574.
    PubMed     Abstract available

  57. MANTHEY J, Solovei A, Anderson P, Carr S, et al
    Can alcohol consumption in Germany be reduced by alcohol screening, brief intervention and referral to treatment in primary health care? Results of a simulation study.
    PLoS One. 2021;16:e0255843.
    PubMed     Abstract available

  58. MINICOZZI MR, Axlid EG, von Hippel FA, Espinoza J, et al
    Perchlorate exposure does not induce obesity or non-alcoholic fatty liver disease in zebrafish.
    PLoS One. 2021;16:e0254500.
    PubMed     Abstract available

  59. DANTAS DMM, Cahu TB, Oliveira CYB, Abadie-Guedes R, et al
    Chlorella vulgaris functional alcoholic beverage: Effect on propagation of cortical spreading depression and functional properties.
    PLoS One. 2021;16:e0255996.
    PubMed     Abstract available

  60. GAUME J, Grazioli VS, Paroz S, Fortini C, et al
    Developing a brief motivational intervention for young adults admitted with alcohol intoxication in the emergency department - Results from an iterative qualitative design.
    PLoS One. 2021;16:e0246652.
    PubMed     Abstract available

  61. O'DONNELL A, Schulte B, Manthey J, Schmidt CS, et al
    Primary care-based screening and management of depression amongst heavy drinking patients: Interim secondary outcomes of a three-country quasi-experimental study in Latin America.
    PLoS One. 2021;16:e0255594.
    PubMed     Abstract available

  62. VAN DEN TOREN SJ, van Grieken A, Raat H
    Associations of socio-demographic characteristics, well-being, school absenteeism, and substance use with recreational nitrous oxide use among adolescents: A cross-sectional study.
    PLoS One. 2021;16:e0247230.
    PubMed     Abstract available

  63. LI M, Hu M, Yue Z, Zhang Y, et al
    The interactive effects of non-alcoholic fatty liver disease and hemoglobin concentration in the first trimester on the development of gestational diabetes mellitus.
    PLoS One. 2021;16:e0257391.
    PubMed     Abstract available

  64. KAPS L, Ahlbrand CJ, Gadban R, Nagel M, et al
    Applicability and safety of discontinuous ADVanced Organ Support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outside of intensive care.
    PLoS One. 2021;16:e0249342.
    PubMed     Abstract available

  65. WANG IJ, Bae BK, Cho YM, Cho SJ, et al
    Effect of acute alcohol intoxication on mortality, coagulation, and fibrinolysis in trauma patients.
    PLoS One. 2021;16:e0248810.
    PubMed     Abstract available

  66. HANNA CHAIM C, Santana GL, de Vries Albertin P, Silveira CM, et al
    Alcohol use patterns and disorders among individuals with personality disorders in the Sao Paulo Metropolitan Area.
    PLoS One. 2021;16:e0248403.
    PubMed     Abstract available

  67. JACKSON J, Donaldson DI, Dering B
    The morning after the night before: Alcohol-induced blackouts impair next day recall in sober young adults.
    PLoS One. 2021;16:e0250827.
    PubMed     Abstract available

  68. KNIGHT JK, Salali GD, Sikka G, Derkx I, et al
    Quantifying patterns of alcohol consumption and its effects on health and wellbeing among BaYaka hunter-gatherers: A mixed-methods cross-sectional study.
    PLoS One. 2021;16:e0258384.
    PubMed     Abstract available

  69. OSCAR-BERMAN M, Ruiz SM, Marinkovic K, Valmas MM, et al
    Brain responsivity to emotional faces differs in men and women with and without a history of alcohol use disorder.
    PLoS One. 2021;16:e0248831.
    PubMed     Abstract available

  70. Retraction: Fructose Mediated Non-Alcoholic Fatty Liver Is Attenuated by HO-1-SIRT1 Module in Murine Hepatocytes and Mice Fed a High Fructose Diet.
    PLoS One. 2021;16:e0259219.

  71. KASHYAP GC, Govind B, Srivastava S, R V, et al
    A true face of Indian married couples: Effect of age and education on control over own sexuality and sexual violence.
    PLoS One. 2021;16:e0254005.
    PubMed     Abstract available

  72. HEITMANN J, van Hemel-Ruiter ME, Huisman M, Ostafin BD, et al
    Effectiveness of attentional bias modification training as add-on to regular treatment in alcohol and cannabis use disorder: A multicenter randomized control trial.
    PLoS One. 2021;16:e0252494.
    PubMed     Abstract available

  73. CHARTIER KG, Guidry JPD, Lee CA, Buckley TD, et al
    At home and online during the early months of the COVID-19 pandemic and the relationship to alcohol consumption in a national sample of U.S. adults.
    PLoS One. 2021;16:e0259947.
    PubMed     Abstract available

  74. HOLMES HM, Jove AG, Tan MC, El-Serag HB, et al
    Alcohol consumption and the risk of gastric intestinal metaplasia in a U.S. Veterans population.
    PLoS One. 2021;16:e0260019.
    PubMed     Abstract available

  75. HOWLETT N, Garcia-Iglesias J, Breslin G, Bartington S, et al
    Remote delivery of alcohol and/or substance misuse interventions for adults: A systematic review protocol.
    PLoS One. 2021;16:e0259525.
    PubMed     Abstract available

  76. FILLMORE N, Bell S, Shen C, Nguyen V, et al
    Disulfiram use is associated with lower risk of COVID-19: A retrospective cohort study.
    PLoS One. 2021;16:e0259061.
    PubMed     Abstract available

  77. LEGAS G, Asnakew S, Belete A, Beyene GM, et al
    Magnitude and correlates of alcohol use disorder in south Gondar zone, northwest Ethiopia: A community based cross-sectional study.
    PLoS One. 2021;16:e0257804.
    PubMed     Abstract available

  78. MINNERLY C, Shokry IM, To W, Callanan JJ, et al
    Characteristic changes in EEG spectral powers of patients with opioid-use disorder as compared with those with methamphetamine- and alcohol-use disorders.
    PLoS One. 2021;16:e0248794.
    PubMed     Abstract available

  79. AGUERREBERE M, Frias SM, Smith Fawzi MC, Lopez R, et al
    Intimate partner violence types and symptoms of common mental disorders in a rural community of Chiapas, Mexico: Implications for global mental-health practice.
    PLoS One. 2021;16:e0256850.
    PubMed     Abstract available

  80. GUTEMA H, Debela Y, Walle B, Reba K, et al
    Predicting binge drinking among university students: Application of integrated behavioral model.
    PLoS One. 2021;16:e0254185.
    PubMed     Abstract available

  81. GOYALE A, Jain A, Smith C, Papatheodoridi M, et al
    Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study.
    PLoS One. 2021;16:e0260313.
    PubMed     Abstract available

  82. JANG DK, Ahn DW, Lee KL, Kim BG, et al
    Impacts of body composition parameters and liver cirrhosis on the severity of alcoholic acute pancreatitis.
    PLoS One. 2021;16:e0260309.
    PubMed     Abstract available

  83. KONRAD G, Leong C, Bolton JM, Prior HJ, et al
    Use of pharmacotherapy for alcohol use disorder in Manitoba, Canada: A whole-population cohort study.
    PLoS One. 2021;16:e0257025.
    PubMed     Abstract available

  84. ALVES RM, Santos EGO, Barbosa IR
    Abuse of alcohol among farmers: Prevalence and associated factors.
    PLoS One. 2021;16:e0254904.
    PubMed     Abstract available

  85. CORDOBA E, Garofalo R, Kuhns LM, Pearson C, et al
    Risk-taking behaviors in adolescent men who have sex with men (MSM): An association between homophobic victimization and alcohol consumption.
    PLoS One. 2021;16:e0260083.
    PubMed     Abstract available

  86. ESKRIDGE W, Vierling JM, Gosbee W, Wan GA, et al
    Screening for undiagnosed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A population-based risk factor assessment using vibration controlled transient elastography (VCTE).
    PLoS One. 2021;16:e0260320.
    PubMed     Abstract available

  87. PARK SJ, Lee SJ, Kim H, Kim JK, et al
    Machine learning prediction of dropping out of outpatients with alcohol use disorders.
    PLoS One. 2021;16:e0255626.
    PubMed     Abstract available

  88. VIGOUROUX A, Garret C, Lascarrou JB, Martin M, et al
    Alcohol withdrawal syndrome in ICU patients: Clinical features, management, and outcome predictors.
    PLoS One. 2021;16:e0261443.
    PubMed     Abstract available

  89. TEVIK K, Bergh S, Selbaek G, Johannessen A, et al
    A systematic review of self-report measures used in epidemiological studies to assess alcohol consumption among older adults.
    PLoS One. 2021;16:e0261292.
    PubMed     Abstract available

  90. MCCRABB S, Mooney K, Wolfenden L, Gonzalez S, et al
    "He who pays the piper calls the tune": Researcher experiences of funder suppression of health behaviour intervention trial findings.
    PLoS One. 2021;16:e0255704.
    PubMed     Abstract available

  91. PERALES JC, Maldonado A, Lopez-Quirantes EM, Lopez-Torrecillas F, et al
    Association patterns of cannabis abuse and dependence with risk of problematic non-substance-related dysregulated and addictive behaviors.
    PLoS One. 2021;16:e0255872.
    PubMed     Abstract available

  92. CHEN Y, Hinton C, VanderWeele TJ
    School types in adolescence and subsequent health and well-being in young adulthood: An outcome-wide analysis.
    PLoS One. 2021;16:e0258723.
    PubMed     Abstract available

  93. SINGINI MG, Sitas F, Bradshaw D, Chen WC, et al
    Ranking lifestyle risk factors for cervical cancer among Black women: A case-control study from Johannesburg, South Africa.
    PLoS One. 2021;16:e0260319.
    PubMed     Abstract available

  94. AKOMBI-INYANG B, Ghimire PR, Archibong E, Woolley E, et al
    Association between intimate partner violence and male alcohol use and the receipt of perinatal care: Evidence from Nepal demographic and health survey 2011-2016.
    PLoS One. 2021;16:e0259980.
    PubMed     Abstract available

  95. RIBEIRO RM, Havik PJ, Craveiro I
    The circuits of healthcare: Understanding healthcare seeking behaviour-A qualitative study with tuberculosis patients in Lisbon, Portugal.
    PLoS One. 2021;16:e0261688.
    PubMed     Abstract available

    January 2020
  96. SAWYER KS, Adra N, Salz DM, Kemppainen MI, et al
    Hippocampal subfield volumes in abstinent men and women with a history of alcohol use disorder.
    PLoS One. 2020;15:e0236641.
    PubMed     Abstract available

  97. SORINO P, Caruso MG, Misciagna G, Bonfiglio C, et al
    Selecting the best machine learning algorithm to support the diagnosis of Non-Alcoholic Fatty Liver Disease: A meta learner study.
    PLoS One. 2020;15:e0240867.
    PubMed     Abstract available

  98. CHEN F, Xiao M, Chen C, Chen C, et al
    Discrimination of alcohol dependence based on the convolutional neural network.
    PLoS One. 2020;15:e0241268.
    PubMed     Abstract available

  99. MANN JP, Carter P, Armstrong MJ, Abdelaziz HK, et al
    Hospital admission with non-alcoholic fatty liver disease is associated with increased all-cause mortality independent of cardiovascular risk factors.
    PLoS One. 2020;15:e0241357.
    PubMed     Abstract available

  100. HENNEIN R, Lowe S
    A hybrid inductive-abductive analysis of health workers' experiences and wellbeing during the COVID-19 pandemic in the United States.
    PLoS One. 2020;15:e0240646.
    PubMed     Abstract available

  101. SAKAMAKI A, Yokoyama K, Koyama K, Morita S, et al
    Obesity and accumulation of subcutaneous adipose tissue are poor prognostic factors in patients with alcoholic liver cirrhosis.
    PLoS One. 2020;15:e0242582.
    PubMed     Abstract available

  102. ADRAWA N, Alege JB, Izudi J
    Alcohol consumption increases non-adherence to ART among people living with HIV enrolled to the community-based care model in rural northern Uganda.
    PLoS One. 2020;15:e0242801.
    PubMed     Abstract available

  103. BAE CR, Zhang H, Kwon YG
    The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice.
    PLoS One. 2020;15:e0243497.
    PubMed     Abstract available

  104. VIANA PVS, Paiva NS, Villela DAM, Bastos LS, et al
    Factors associated with death in patients with tuberculosis in Brazil: Competing risks analysis.
    PLoS One. 2020;15:e0240090.
    PubMed     Abstract available

  105. LUONG XG, Stevens SK, Jekle A, Lin TI, et al
    Regulation of gene transcription by thyroid hormone receptor beta agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH).
    PLoS One. 2020;15:e0240338.
    PubMed     Abstract available

  106. VORNHOLT E, Drake J, Mamdani M, McMichael G, et al
    Network preservation reveals shared and unique biological processes associated with chronic alcohol abuse in NAc and PFC.
    PLoS One. 2020;15:e0243857.
    PubMed     Abstract available

  107. RADCLIFFE RA, Dowell R, Odell AT, Richmond PA, et al
    Systems genetics analysis of the LXS recombinant inbred mouse strains:Genetic and molecular insights into acute ethanol tolerance.
    PLoS One. 2020;15:e0240253.
    PubMed     Abstract available

  108. FRANK K, Abeynaike S, Nikzad R, Patel RR, et al
    Alcohol dependence promotes systemic IFN-gamma and IL-17 responses in mice.
    PLoS One. 2020;15:e0239246.
    PubMed     Abstract available

  109. SEMMLER G, Bachmayer S, Wernly S, Wernly B, et al
    Nut consumption and the prevalence and severity of non-alcoholic fatty liver disease.
    PLoS One. 2020;15:e0244514.
    PubMed     Abstract available

  110. KILIAN C, Manthey J, Moskalewicz J, Scafato E, et al
    Comparing subjective intoxication with risky single-occasion drinking in a European sample.
    PLoS One. 2020;15:e0241433.
    PubMed     Abstract available

  111. LONG JE, Richardson BA, Wanje G, Wilson KS, et al
    Alcohol use and viral suppression in HIV-positive Kenyan female sex workers on antiretroviral therapy.
    PLoS One. 2020;15:e0242817.
    PubMed     Abstract available

  112. TAVANASEFAT H, Li F, Koyano K, Gourtani BK, et al
    Molecular consequences of fetal alcohol exposure on amniotic exosomal miRNAs with functional implications for stem cell potency and differentiation.
    PLoS One. 2020;15:e0242276.
    PubMed     Abstract available

  113. KAN CK, Ragan EJ, Sarkar S, Knudsen S, et al
    Alcohol use and tuberculosis clinical presentation at the time of diagnosis in Puducherry and Tamil Nadu, India.
    PLoS One. 2020;15:e0240595.
    PubMed     Abstract available

  114. SEGHER K, Huys L, Desmet T, Steen E, et al
    Recognition of a disulfiram ethanol reaction in the emergency department is not always straightforward.
    PLoS One. 2020;15:e0243222.
    PubMed     Abstract available

  115. BITEW MS, Zewde MF, Wubetu M, Alemu AA, et al
    Consumption of alcohol and binge drinking among pregnant women in Addis Ababa, Ethiopia: Prevalence and determinant factors.
    PLoS One. 2020;15:e0243784.
    PubMed     Abstract available

  116. IGLESIAS K, Lannoy S, Sporkert F, Daeppen JB, et al
    Performance of self-reported measures of alcohol use and of harmful drinking patterns against ethyl glucuronide hair testing among young Swiss men.
    PLoS One. 2020;15:e0244336.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alcoholism is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.